85631-006-01-gout Relief 3310-s-new
3dbf3436-16b9-b793-e063-6394a90a1e71
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
MEDICAGO SATIVA WHOLE 20.00% CHICORY ROOT 23.00% GLUCOSAMINE HYDROCHLORIDE 10.00% BUCKWHEAT 7.00% TEA LEAF 5.00% MORUS ALBA LEAF 13.00% LICORICE 0.20% FU LING 2.00% COIX LACRYMA-JOBI SEED 8.00%
Medication Information
Warnings and Precautions
For your health, please read the followingcarefully
1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
5. This product certainly has significant effect on gout,crystallization and hyperuricemia;
Indications and Usage
Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus
Dosage and Administration
The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;
Description
MEDICAGO SATIVA WHOLE 20.00% CHICORY ROOT 23.00% GLUCOSAMINE HYDROCHLORIDE 10.00% BUCKWHEAT 7.00% TEA LEAF 5.00% MORUS ALBA LEAF 13.00% LICORICE 0.20% FU LING 2.00% COIX LACRYMA-JOBI SEED 8.00%
Section 50565-1
Keep out of reach of children
Section 51727-6
This product has a significanteffect on gout, crystal deposits,and hyperuricemia;
elt has an auxiliary effectof mitigating kidney stonesand bladder stones
Section 51945-4
Section 55105-1
This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones
Section 55106-9
MEDICAGO SATIVA WHOLE 20.00%
CHICORY ROOT 23.00%
GLUCOSAMINE HYDROCHLORIDE 10.00%
BUCKWHEAT 7.00%
TEA LEAF 5.00%
MORUS ALBA LEAF 13.00%
LICORICE 0.20%
FU LING 2.00%
COIX LACRYMA-JOBI SEED 8.00%
Section 60561-8
Do not use if seal is broken.
Do not eat freshness packet enclosed.
Keep out of direct sunlight, high temperature, and humidity.
Store in a cool, dry place.
Structured Label Content
Indications and Usage (34067-9)
Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus
Dosage and Administration (34068-7)
The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;
Warnings and Precautions (34071-1)
For your health, please read the followingcarefully
1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
5. This product certainly has significant effect on gout,crystallization and hyperuricemia;
Section 50565-1 (50565-1)
Keep out of reach of children
Section 51727-6 (51727-6)
This product has a significanteffect on gout, crystal deposits,and hyperuricemia;
elt has an auxiliary effectof mitigating kidney stonesand bladder stones
Section 51945-4 (51945-4)
Section 55105-1 (55105-1)
This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones
Section 55106-9 (55106-9)
MEDICAGO SATIVA WHOLE 20.00%
CHICORY ROOT 23.00%
GLUCOSAMINE HYDROCHLORIDE 10.00%
BUCKWHEAT 7.00%
TEA LEAF 5.00%
MORUS ALBA LEAF 13.00%
LICORICE 0.20%
FU LING 2.00%
COIX LACRYMA-JOBI SEED 8.00%
Section 60561-8 (60561-8)
Do not use if seal is broken.
Do not eat freshness packet enclosed.
Keep out of direct sunlight, high temperature, and humidity.
Store in a cool, dry place.
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:12:06.068652 · Updated: 2026-03-14T23:17:29.613906